Advanced Accelerator Applications Announces European Commission Approval of SomaKit TOC™
15 déc. 2016 07h00 HE
|
Advanced Accelerator Applications
SAINT-GENIS-POUILLY, France, Dec. 15, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or “the Company”), an international specialist in molecular nuclear...
Advanced Accelerator Applications Announces CMS Pass-Through Reimbursement Code for its First FDA Approved Drug NETSPOT®
08 déc. 2016 07h00 HE
|
Advanced Accelerator Applications
SAINT-GENIS-POUILLY, France, Dec. 08, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or “the Company”), an international specialist in Molecular Nuclear...
Advanced Accelerator Applications Reports 15.4% Sales Growth in the Third Quarter of 2016 and Feedback from the FDA for Lutathera®, an Investigational Treatment for Neuroendocrine Tumors
28 nov. 2016 07h00 HE
|
Advanced Accelerator Applications
Conference Call Today at 4:30 p.m. ET Highlights: Sales for the third quarter of 2016 increased 15.4% compared to the third quarter of 2015Closed $150 million follow-on public offering and...
Advanced Accelerator Applications to Announce Third Quarter and Nine-Month 2016 Financial Results on November 28
23 nov. 2016 07h30 HE
|
Advanced Accelerator Applications
SAINT-GENIS-POUILLY, France, Nov. 23, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or “the Company”), an international specialist in Molecular Nuclear...
Advanced Accelerator Applications Announces Swiss Marketing Authorization for Two PET Diagnostic Products
02 nov. 2016 07h00 HE
|
Advanced Accelerator Applications
SAINT-GENIS-POUILLY, France, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or “the Company”), an international specialist in molecular nuclear...
Advanced Accelerator Applications Announces Positive EMA Opinion on Application for SomaKit TOC
17 oct. 2016 07h00 HE
|
Advanced Accelerator Applications
SAINT-GENIS-POUILLY, France, Oct. 17, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or “the Company”), an international specialist in molecular nuclear...
Advanced Accelerator Applications Announces Presentations on Lutathera® NETTER-1 Phase III and NeoBOMB1 at EANM
11 oct. 2016 07h00 HE
|
Advanced Accelerator Applications
SAINT-GENIS-POUILLY, France, Oct. 11, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or the “Company”), an international specialist in Molecular Nuclear...
Advanced Accelerator Applications S.A. Announces Pricing of $150 Million Public Offering of American Depositary Shares
05 oct. 2016 19h27 HE
|
Advanced Accelerator Applications
NEW YORK, Oct. 05, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or the “Company”), an international specialist in Molecular Nuclear Medicine (MNM), today...
Advanced Accelerator Applications S.A. Announces Proposed Public Offering of American Depositary Shares
04 oct. 2016 16h00 HE
|
Advanced Accelerator Applications
SAINT-GENIS-POUILLY, France, Oct. 04, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or the “Company”), an international specialist in Molecular Nuclear...
EMA Prematurely Announced Opinion on SomaKit TOC® Kit Application
22 sept. 2016 13h00 HE
|
Advanced Accelerator Applications
SAINT-GENIS-POUILLY, France, Sept. 22, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or “the Company”), an international specialist in molecular nuclear...